SEC Filing Summary: Seneca Biopharma, Inc. (SNCA)
Business Context and Reporting Period
This Form 8-K was filed on June 12, 2020, by Seneca Biopharma, Inc. (Note: The request metadata referenced "Palisade Bio, Inc.", but the filing text explicitly identifies the registrant as Seneca Biopharma, Inc.). The report covers events occurring on June 10, 2020, regarding the scheduling of the 2020 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance and does not contain financial statements.
Material Changes
The Board of Directors established August 7, 2020, as the date for the 2020 Annual Meeting of Stockholders. This date represents a change of more than 30 days from the anniversary of the 2019 Annual Meeting. Consequently, the Company set June 15, 2020, as the record date for the meeting.
Guidance, Outlook, and Corporate Actions
Due to the change in the Annual Meeting date, the Company provided specific deadlines for shareholder proposals and director nominations:
- Record Date: June 15, 2020.
- Proposal Deadline: Stockholder proposals or nominations for inclusion in the proxy statement pursuant to Rule 14a-8 must be received by 5:00 p.m. Eastern Time on June 22, 2020.
- Compliance: Proposals must comply with SEC rules (Rule 14a-8) and the Company's amended and restated bylaws.
Key Facts for Investor Verification
- Verify the correct registrant name is Seneca Biopharma, Inc., not Palisade Bio, Inc.
- Confirm the Annual Meeting date is August 7, 2020.
- Note the strict deadline of June 22, 2020, for submitting stockholder proposals for the upcoming proxy statement.
- Check the record date of June 15, 2020, to determine eligibility to vote at the Annual Meeting.